1. Home
  2. SNGX vs IPDN Comparison

SNGX vs IPDN Comparison

Compare SNGX & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.37

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Logo Professional Diversity Network Inc.

IPDN

Professional Diversity Network Inc.

HOLD

Current Price

$0.15

Market Cap

6.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
IPDN
Founded
1987
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
6.6M
IPO Year
2006
2012

Fundamental Metrics

Financial Performance
Metric
SNGX
IPDN
Price
$0.37
$0.15
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
205.9K
2.3M
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
N/A
EPS
N/A
N/A
Revenue
$119,371.00
$22,054,219.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.11
52 Week High
$2.98
$5.07

Technical Indicators

Market Signals
Indicator
SNGX
IPDN
Relative Strength Index (RSI) 40.30 35.66
Support Level $0.36 N/A
Resistance Level $0.42 $0.45
Average True Range (ATR) 0.02 0.03
MACD -0.00 0.01
Stochastic Oscillator 7.46 39.69

Price Performance

Historical Comparison
SNGX
IPDN

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc provides access to networking, training, educational, and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates the majority of its revenue from the TalentAlly Network Segment.

Share on Social Networks: